Iloperidone - CAS 133454-47-4
Catalog number: 133454-47-4
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
5-HT Receptor
Iloperidone displays high affinity (Ki < 10 nM) for norepinephrine alpha(1)-adrenoceptors, dopamine D(3) and serotonin 5-HT(2A) receptors.
HP873; HP 873; HP-873
Canonical SMILES:
1.A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder.
Ionescu DF1, Fava M2, Kim DJ3, Baer L1, Shelton RC4, Cusin C1. Ther Adv Psychopharmacol. 2016 Feb;6(1):4-12. doi: 10.1177/2045125315618621.
BACKGROUND: Even when patients experience remission with antidepressants, many continue to report anger attacks and excessive irritability despite continued treatment. Iloperidone antagonizes 5-HT-2a, D2, and alpha-1 receptors, which can have anti-aggressive effects. We examined iloperidone's safety and efficacy as an augmentation agent in outpatients with partially remitted major depressive disorder (MDD) with residual symptoms of anger and irritability.
2.Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.
Khokhar JY1, Green AI2. Neuropharmacology. 2016 Jan 12;105:25-34. doi: 10.1016/j.neuropharm.2016.01.017. [Epub ahead of print]
Alcohol use disorder in patients with schizophrenia dramatically worsens their clinical course, and few treatment options are available. Clozapine appears to reduce alcohol use in these patients, but its toxicity limits its use. To create a safer clozapine-like drug, we tested whether the antipsychotic iloperidone, a drug that combines a weak dopamine D2 receptor blockade and a potent norepinephrine alpha-2 receptor blockade would reduce alcohol drinking, and whether its effect on alcohol drinking could be increased if combined with an agent to facilitate norepinephrine activity. Syrian golden hamsters (useful animal model for screening drugs that reduce alcohol drinking in patients with schizophrenia) were given free access to water and alcohol (15% v/v) until stable drinking was established. Animals (n = 6-7/group), matched according to alcohol intake, were treated daily with each drug (iloperidone; clozapine; haloperidol; desipramine [norepinephrine reuptake inhibitor]; with idazoxan [norepinephrine alpha-2 receptor antagonist]) or with a two-drug (iloperidone + desipramine; iloperidone + idazoxan) combination for 14 days.
3.Flow Synthesis in Hot Water: Synthesis of the Atypical Antipsychotic Iloperidone.
Hartwig J1, Kirschning A2. Chemistry. 2016 Feb;22(9):3044-52. doi: 10.1002/chem.201504409. Epub 2016 Jan 25.
Inductively heated steel reactors continuously perform organic transformations in water under high temperature conditions, utilizing the unique physiochemical properties of water at subcritical conditions. We demonstrated the power of this set-up in the continuous synthesis of the atypical antipsychotic drug iloperidone, in which we performed four out of five steps under aqueous conditions.
4.Iloperidone-induced ejaculatory dysfunction: A case series.
Ravani NN1, Katke PH2. Indian J Psychiatry. 2016 Jan-Mar;58(1):87-9. doi: 10.4103/0019-5545.174392.
Disorders of ejaculation are the consequences of surgical procedures and with the use of various drugs. Until date, most drugs reported to induce ejaculatory dysfunctions such as retrograde ejaculation or dry orgasms share the capacity to significantly antagonize alpha 1-adrenergic receptor. Iloperidone, a new dopamine Type 2 and serotonin Type 2A antagonist similar to risperidone, provides better efficacy with lesser extra-pyramidal side effects. In addition, it also antagonize alpha 1-adrenergic receptor and alpha-2C receptors. Limited data is available for iloperidone-induced ejaculation dysfunction. This article features five schizophrenic patients which developed retrograde ejaculation during treatment with iloperidone. The ejaculatory dysfunction following treatment with iloperidone could be postulated due to blocking of alpha 1-adrenergic receptor.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products

CAS 123040-16-4 Azasetron hydrochloride

Azasetron hydrochloride
(CAS: 123040-16-4)

Azasetron HCl is a selective 5-HT3 receptor antagonist with IC50 of 0.33 nM used in the management of nausea and vomiting induced by cancer chemotherapy.

CAS 845861-39-4 CP 94253 hydrochloride

CP 94253 hydrochloride
(CAS: 845861-39-4)

The hydrochloride salt form of CP 94253, which is a 5-HT1B agonist and exhibit anticonvulsant activities.

CAS 17692-51-2 Metergoline

(CAS: 17692-51-2)

Metergoline is a serotonin (5-HT) receptor antagonist that is active at 5-HT1 (pKi = 7.8 for 5-HT1B), 5-HT2, (pKi = 8.64, 8.75, and 8.75 for 5-HT2A, 5-HT2B, and...

(CAS: 607742-80-3)

GSK215083 is a PET radioligand for the 5-hydroxytrypamine-6 (5HT6) receptor. It is a quinoline based compounds that acts by antagonising the 5-HT6 receptor. It ...

CAS 26328-11-0 (S)-(-)-Pindolol

(CAS: 26328-11-0)

(S)-(-)-Pindolol, the more active enantiomer of pindolol, is 5-HT1A/1B receptor antagonist, with roughly equal affinity for each subtype.

CAS 168986-60-5 RS 67333 hydrochloride

RS 67333 hydrochloride
(CAS: 168986-60-5)

RS 67333 hydrochloride is a selective, high affinity partial agonist toward 5-HT4 receptor with pKi values of 8.7 at 5-HT4 sites in guinea pig striatum and > 6 ...

CAS 10457-90-6 Bromperidol

(CAS: 10457-90-6)

Bromperidol, a derivative of butyrophenone, is an antipsychotic commonly used in the treatment of schizophrenia as it could bind to the D2 dopamine and 5-HT2A s...

Risperidone hydrochloride
(CAS: 666179-74-4)

Risperidone is a serotonin 5-HT2 receptor blocker and a potent dopamine D2 receptor antagonist.

Chemical Structure

CAS 133454-47-4 Iloperidone

Quick Inquiry

Verification code

Featured Items